TMDX Investor News: Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX
1. Rosen Law Firm investigates potential securities claims against TMDX. 2. Accusations suggest TMDX issued misleading business information to investors. 3. Stock dropped 5.15% and 6.9% on January 10 and 13, 2025. 4. Scorpion Capital labeled TMDX a major healthcare fraud incident. 5. Investors may seek compensation without upfront costs through class action.